Jessica Kendall serves as the Director of Operations and Corporate Compliance Officer at Lexar Labs, where she leverages her extensive background in biotechnology and medical sales to drive operational excellence and ensure adherence to regulatory standards. With a keen focus on strategic development, Jessica is...
Jessica Kendall serves as the Director of Operations and Corporate Compliance Officer at Lexar Labs, where she leverages her extensive background in biotechnology and medical sales to drive operational excellence and ensure adherence to regulatory standards. With a keen focus on strategic development, Jessica is instrumental in reviewing and refining Lexar’s service offerings to align with emerging market needs and growth opportunities. Her expertise in consultative sales and territory design enables her to identify and implement innovative programs that enhance clinical functions and improve overall service delivery.
In her role, Jessica oversees a diverse array of activities, including quality assurance, compliance management, and direct marketing initiatives. She collaborates closely with the leadership and management teams to streamline program planning and execution, ensuring that staffing and operational strategies are optimized for success. Her ability to engage with Integrated Delivery Networks (IDNs), hospital groups, and Group Purchasing Organizations (GPOs) has been pivotal in expanding Lexar’s market presence and fostering long-term partnerships.
Jessica’s proficiency in cold calling, account management, and customer retention complements her strategic vision, allowing her to effectively navigate the complexities of B2B sales in the healthcare sector. Her technical presentation skills and problem-solving capabilities further enhance her ability to communicate value propositions to stakeholders, making her a vital asset to Lexar Labs. As she continues to drive growth and innovation within the organization, Jessica remains committed to upholding the highest standards of quality and compliance, ensuring that Lexar Labs remains a trusted leader in the biotechnology industry.
